Bayesian Capital Management’s MarineMax HZO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,300
Closed -$213K 916
2022
Q1
$213K Buy
+5,300
New +$249K 0.03% 633
2019
Q2
Sell
-11,538
Closed -$221K 588
2019
Q1
$221K Buy
+11,538
New +$220K 0.04% 453
2018
Q3
Sell
-10,775
Closed -$204K 703
2018
Q2
$204K Hold
10,775
0.05% 514
2018
Q1
$210K Hold
10,775
0.05% 492
2017
Q4
$204K Buy
+10,775
New +$207K 0.04% 490

Other funds holding HZO

Bayesian Capital Management's HZO Position: Q2 2022 in Review

Bayesian Capital Management sold out of MarineMax (HZO) in Q2 2022, closing a stake of 5,300 shares — an estimated $213K sold.

Bayesian Capital Management first reported a position in HZO in Q4 2017 and held it in 5 quarters. The position peaked at $221K in Q1 2019. 212 funds tracked by Wall St. Rank hold HZO as of Q2 2022.

  • Bayesian Capital Management reported no remaining MarineMax position as of Q2 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 5,300 MarineMax shares in Q2 2022, an estimated $213K.
  • Bayesian Capital Management first reported a position in MarineMax in Q4 2017 and held it in 5 quarters.
  • Bayesian Capital Management's MarineMax position peaked at $221K in Q1 2019.
  • 212 funds tracked by Wall St. Rank held MarineMax as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.